Patents by Inventor Ravindra Dhanantwari

Ravindra Dhanantwari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120207828
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Application
    Filed: April 6, 2012
    Publication date: August 16, 2012
    Applicant: THREE RIVERS PHARMACEUTICALS, LLC
    Inventors: Donald Joseph KERRISH, Ravindra DHANANTWARI
  • Publication number: 20100203127
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Application
    Filed: April 16, 2010
    Publication date: August 12, 2010
    Applicant: Three Rivers Pharmaceuticals, LLC
    Inventors: Donald Joseph Kerrish, Ravindra Dhanantwari
  • Patent number: 7723310
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: May 25, 2010
    Assignee: Three Rivers Pharmaceuticals, LLC
    Inventors: Donald Joseph Kerrish, Ravindra Dhanantwari
  • Publication number: 20090012015
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Application
    Filed: September 19, 2008
    Publication date: January 8, 2009
    Applicant: Three Rivers Pharmaceuticals, LLC
    Inventors: Donald Joseph KERRISH, Ravindra Dhanantwari
  • Publication number: 20070161583
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Application
    Filed: March 30, 2007
    Publication date: July 12, 2007
    Applicant: THREE RIVERS PHARMACEUTICALS, LLC
    Inventors: Donald Kerrish, Ravindra Dhanantwari
  • Publication number: 20060083785
    Abstract: The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin.
    Type: Application
    Filed: August 11, 2005
    Publication date: April 20, 2006
    Inventors: Donald Kerrish, Ravindra Dhanantwari